Alkermes ALKS
NASDAQ ALKS
$43.77 -0.34 (-0.77%)
As of: Oct 21, 2026 · 10:48 AM EDT

Alkermes (ALKS) Equity Income (2015 - 2017)

Updated

Alkermes (ALKS) posted Equity Income of $8.3 million for FY2020, compared with -$400,000 in FY2019.

Analysis

Alkermes (ALKS) Equity Income (2015 - 2017) Analysis & Trends

Since FY2012, Alkermes has reported Equity Income for 9 years.

  • Annual Equity Income shows a five-year compound annual growth rate of 110.7% (FY2015 to FY2020).
  • The FY2020 figure stands as the highest annual Equity Income in data going back to FY2012.
  • Business Quant data shows ALKS's Equity Income at -$400,000 in FY2019, $500,000 in FY2018, -$2.9 million in FY2017 and -$400,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn -
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn -
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn -
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn -10.00 Mn
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn -
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn -
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn -
10 Alkermes 7.31 Bn 4.44 Bn 397.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -1.20 Mn
Mar 31, 2017 -1.60 Mn
Sep 30, 2015 100,000.00
Mar 31, 2015 100,000.00
API Access

Alkermes Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY